{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:57Z","timestamp":1792603017708,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Donor selection determines the occurrence of acute graft-versus-host-disease (aGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT). To optimize the current clinical donor selection criteria and identify putative donor lymphocyte subsets associated with better recipient outcomes, we analyzed the peripheral CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> subsets in 80 granulocyte colony-stimulating factor (G-CSF) mobilized donors and examined the aGVHD incidence of the corresponding 80 haploidentical and identical allo-HSCT recipients. The G-CSF-induced expansion of subsets varied among donors. We discovered a novel PD-1<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>CD45RA<jats:sup>+<\/jats:sup>CCR7<jats:sup>+<\/jats:sup> T lymphocyte subset in suitable donors that was significantly correlated with lower incidence of aGVHD and post-transplant anti-infection. The anti-aGVHD activity of this subset was confirmed in a validation cohort (<jats:italic>n<\/jats:italic>\u2009=\u200930). Single-cell RNA sequencing revealed that this T cell subset exhibited transcriptomic features of stem cell-like memory T cell (T<jats:sub>SCM<\/jats:sub>) with both Treg and Teff activities which indicated its dual functions in aGVHD inhibition and graft-versus-leukemia (GVL) effect. Intriguingly, upon G-CSF mobilization, the donor PD-1<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T<jats:sub>SCM<\/jats:sub>-like regulatory cells increased the PD-1 expression in a BCL6-dependent manner. Next, we showed that the mouse counterpart of this subset (PD-1<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>CD44<jats:sup>\u2212<\/jats:sup>CD62L<jats:sup>+<\/jats:sup>) ameliorated aGVHD, and confirmed the existence of this subset in clinical recipients. In summary, we, for the first time, identified a novel donor peripheral T cell subset suppressing aGVHD while promoting the immune reconstitution of recipients. It may serve as an indicator for optimal haploidentical and identical donor selection. Importantly, the dual Treg and Teff function of these T cells makes it a promising treatment for not only aGVHD but also auto-immune diseases.<\/jats:p>","DOI":"10.1038\/s41392-025-02183-1","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:01:54Z","timestamp":1743786114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A donor PD-1+CD8+ TSCM-like regulatory subset mobilized by G-CSF alleviates recipient acute graft-versus-host-disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-1195","authenticated-orcid":false,"given":"Jiong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-966X","authenticated-orcid":false,"given":"Liming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2183_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1056\/NEJMp078166","volume":"357","author":"FR Appelbaum","year":"2007","unstructured":"Appelbaum, F. R. Hematopoietic-cell transplantation at 50. N. Engl. J. Med. 357, 1472\u20131475 (2007).","journal-title":"N. Engl. J. Med."},{"key":"2183_CR2","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","volume":"301","author":"J Koreth","year":"2009","unstructured":"Koreth, J. et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301, 2349\u20132361 (2009).","journal-title":"JAMA"},{"key":"2183_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner, H. et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129, 424\u2013447 (2017).","journal-title":"Blood"},{"key":"2183_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/stem.140090","volume":"14","author":"WI Bensinger","year":"1996","unstructured":"Bensinger, W. I. et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 14, 90\u2013105 (1996).","journal-title":"Stem Cells"},{"key":"2183_CR5","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1200\/JCO.1989.7.12.1791","volume":"7","author":"KM Taylor","year":"1989","unstructured":"Taylor, K. M. et al. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin\u2019s disease. J. Clin. Oncol. 7, 1791\u20131799 (1989).","journal-title":"J. Clin. Oncol."},{"key":"2183_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3389\/fimmu.2018.00845","volume":"9","author":"GK Melve","year":"2018","unstructured":"Melve, G. K., Ersvaer, E., Eide, G. E., Kristoffersen, E. K. & Bruserud, O. Peripheral blood stem cell mobilization in healthy donors by granulocyte colony-stimulating factor causes preferential mobilization of lymphocyte subsets. Front. Immunol. 9, 845 (2018).","journal-title":"Front. Immunol."},{"key":"2183_CR7","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3389\/fimmu.2019.02516","volume":"10","author":"YJ Chang","year":"2019","unstructured":"Chang, Y. J., Zhao, X. Y. & Huang, X. J. Granulocyte colony-stimulating factor-primed unmanipulated haploidentical blood and marrow transplantation. Front. Immunol. 10, 2516 (2019).","journal-title":"Front. Immunol."},{"key":"2183_CR8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1182\/blood-2007-07-097543","volume":"111","author":"P Anderlini","year":"2008","unstructured":"Anderlini, P. & Champlin, R. E. Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111, 1767\u20131772 (2008).","journal-title":"Blood"},{"key":"2183_CR9","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Acute graft-versus-host disease\u2014biologic process, prevention, and therapy. N. Engl. J. Med. 377, 2167\u20132179 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2183_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JLM Ferrara","year":"2009","unstructured":"Ferrara, J. L. M., Levine, J. E., Reddy, P. & Holler, E. Graft-versus-host disease. Lancet 373, 1550\u20131561 (2009).","journal-title":"Lancet"},{"key":"2183_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","volume":"112","author":"BE Anderson","year":"2003","unstructured":"Anderson, B. E. et al. Memory CD4+ T cells do not induce graft-versus-host disease. J. Clin. Invest. 112, 101\u2013108 (2003).","journal-title":"J. Clin. Invest."},{"key":"2183_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","volume":"66","author":"PJ Martin","year":"1985","unstructured":"Martin, P. J. et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66, 664\u2013672 (1985).","journal-title":"Blood"},{"key":"2183_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.7326\/0003-4819-104-5-619","volume":"104","author":"JD Pirsch","year":"1986","unstructured":"Pirsch, J. D. & Maki, D. G. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann. Intern. Med. 104, 619\u2013631 (1986).","journal-title":"Ann. Intern. Med."},{"key":"2183_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1586\/ehm.10.32","volume":"3","author":"AJ Barrett","year":"2010","unstructured":"Barrett, A. J. & Battiwalla, M. Relapse after allogeneic stem cell transplantation. Expert Rev. Hematol. 3, 429\u2013441 (2010).","journal-title":"Expert Rev. Hematol."},{"key":"2183_CR15","doi-asserted-by":"crossref","unstructured":"Biernacki, M. A., Sheth, V. S. & Bleakley, M. T cell optimization for graft-versus-leukemia responses. JCI Insight 5, e134939 (2020).","DOI":"10.1172\/jci.insight.134939"},{"key":"2183_CR16","doi-asserted-by":"publisher","first-page":"680841","DOI":"10.1155\/2012\/680841","volume":"2012","author":"M Park","year":"2012","unstructured":"Park, M. & Seo, J. J. Role of HLA in hematopoietic stem cell transplantation. Bone Marrow Res. 2012, 680841 (2012).","journal-title":"Bone Marrow Res."},{"key":"2183_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-016-0265-2","volume":"9","author":"YJ Chang","year":"2016","unstructured":"Chang, Y. J., Luznik, L., Fuchs, E. J. & Huang, X. J. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? J. Hematol. Oncol. 9, 35 (2016).","journal-title":"J. Hematol. Oncol."},{"key":"2183_CR18","doi-asserted-by":"publisher","first-page":"136.e131","DOI":"10.1016\/j.jtct.2022.11.011","volume":"29","author":"LP Xu","year":"2023","unstructured":"Xu, L. P. et al. Hematopoietic stem cell transplantation activity in China 2020-2021 during the SARS-CoV-2 pandemic: a report from the Chinese Blood and Marrow Transplantation Registry Group. Transpl. Cell Ther. 29, 136.e131\u2013136.e137 (2023).","journal-title":"Transpl. Cell Ther."},{"key":"2183_CR19","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1182\/bloodadvances.2023012133","volume":"8","author":"J Sanz","year":"2024","unstructured":"Sanz, J. et al. Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT. Blood Adv. 8, 2332\u20132341 (2024).","journal-title":"Blood Adv."},{"key":"2183_CR20","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.bbmt.2019.05.031","volume":"25","author":"E Karam","year":"2019","unstructured":"Karam, E. et al. Who is a better donor for recipients of allogeneic hematopoietic cell transplantation: a young HLA-mismatched haploidentical relative or an older fully HLA-matched sibling or unrelated donor? Biol. Blood Marrow Transpl. 25, 2054\u20132060 (2019).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"2183_CR21","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3389\/fimmu.2020.01854","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen, S. & Zeiser, R. Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation. Front. Immunol. 11, 1854 (2020).","journal-title":"Front. Immunol."},{"key":"2183_CR22","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2018-02-791509","volume":"131","author":"S Paczesny","year":"2018","unstructured":"Paczesny, S. Biomarkers for posttransplantation outcomes. Blood 131, 2193\u20132204 (2018).","journal-title":"Blood"},{"key":"2183_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.exphem.2016.07.013","volume":"44","author":"A Widman","year":"2016","unstructured":"Widman, A. & Reshef, R. Precision in donor selection: identifying ideal stem-cell donors through their T cells. Exp. Hematol. 44, 1020\u20131023 (2016).","journal-title":"Exp. Hematol."},{"key":"2183_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/eji.201747134","volume":"48","author":"YLT Chan","year":"2018","unstructured":"Chan, Y. L. T. et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur. J. Immunol. 48, 316\u2013329 (2018).","journal-title":"Eur. J. Immunol."},{"key":"2183_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00277-020-04031-4","volume":"99","author":"A Garnier","year":"2020","unstructured":"Garnier, A. et al. Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide. Ann. Hematol. 99, 1341\u20131350 (2020).","journal-title":"Ann. Hematol."},{"key":"2183_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41421-022-00417-y","volume":"8","author":"G You","year":"2022","unstructured":"You, G. et al. Decoding lymphomyeloid divergence and immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq. Cell Discov. 8, 59 (2022).","journal-title":"Cell Discov."},{"key":"2183_CR27","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.4049\/jimmunol.1502023","volume":"197","author":"SM Perobelli","year":"2016","unstructured":"Perobelli, S. M. et al. G-CSF-induced suppressor IL-10+ neutrophils promote regulatory T cells that inhibit graft-versus-host disease in a long-lasting and specific way. J. Immunol. 197, 3725\u20133734 (2016).","journal-title":"J. Immunol."},{"key":"2183_CR28","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","volume":"95","author":"M Arpinati","year":"2000","unstructured":"Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E. & Anasetti, C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95, 2484\u20132490 (2000).","journal-title":"Blood"},{"key":"2183_CR29","doi-asserted-by":"publisher","first-page":"281ra242","DOI":"10.1126\/scitranslmed.3010435","volume":"7","author":"M D\u2019Aveni","year":"2015","unstructured":"D\u2019Aveni, M. et al. G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease. Sci. Transl. Med. 7, 281ra242 (2015).","journal-title":"Sci. Transl. Med."},{"key":"2183_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200978","volume":"9","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. Multiomics analysis identifies SOCS1 as restraining T cell activation and preventing graft-versus-host disease. Adv. Sci. 9, e2200978 (2022).","journal-title":"Adv. Sci."},{"key":"2183_CR31","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood-2001-12-0291","volume":"100","author":"S Rutella","year":"2002","unstructured":"Rutella, S. et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100, 2562\u20132571 (2002).","journal-title":"Blood"},{"key":"2183_CR32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1182\/blood-2003-08-2864","volume":"103","author":"ES Morris","year":"2004","unstructured":"Morris, E. S. et al. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 103, 3573\u20133581 (2004).","journal-title":"Blood"},{"key":"2183_CR33","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","volume":"86","author":"L Pan","year":"1995","unstructured":"Pan, L., Delmonte, J. Jr., Jalonen, C. K. & Ferrara, J. L. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86, 4422\u20134429 (1995).","journal-title":"Blood"},{"key":"2183_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/blood-2002-04-1200","volume":"102","author":"A Franzke","year":"2003","unstructured":"Franzke, A. et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102, 734\u2013739 (2003).","journal-title":"Blood"},{"key":"2183_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1532\/IJH97.A10227","volume":"79","author":"SH Chen","year":"2004","unstructured":"Chen, S. H., Li, X. & Huang, X. J. Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int. J. Hematol. 79, 178\u2013184 (2004).","journal-title":"Int. J. Hematol."},{"key":"2183_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.12.006","volume":"70","author":"JZ Yang","year":"2016","unstructured":"Yang, J. Z., Zhang, J. Q. & Sun, L. X. Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor. Mol. Immunol. 70, 56\u201362 (2016).","journal-title":"Mol. Immunol."},{"key":"2183_CR37","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.3389\/fimmu.2018.03041","volume":"9","author":"YJ Chang","year":"2018","unstructured":"Chang, Y. J., Zhao, X. Y. & Huang, X. J. Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease. Front. Immunol. 9, 3041 (2018).","journal-title":"Front. Immunol."},{"key":"2183_CR38","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.4049\/jimmunol.175.11.7085","volume":"175","author":"S Rutella","year":"2005","unstructured":"Rutella, S., Zavala, F., Danese, S., Kared, H. & Leone, G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 175, 7085\u20137091 (2005).","journal-title":"J. Immunol."},{"key":"2183_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1399-0012.2010.01298.x","volume":"25","author":"YJ Chang","year":"2011","unstructured":"Chang, Y. J. & Huang, X. J. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin. Transpl. 25, 13\u201323 (2011).","journal-title":"Clin. Transpl."},{"key":"2183_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4049\/jimmunol.171.3.1272","volume":"171","author":"BR Blazar","year":"2003","unstructured":"Blazar, B. R. et al. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. J. Immunol. 171, 1272\u20131277 (2003).","journal-title":"J. Immunol."},{"key":"2183_CR41","doi-asserted-by":"publisher","first-page":"724","DOI":"10.4049\/jimmunol.1102630","volume":"188","author":"X Li","year":"2012","unstructured":"Li, X. et al. Loss of B7-H1 expression by recipient parenchymal cells leads to expansion of infiltrating donor CD8+ T cells and persistence of graft-versus-host disease. J. Immunol. 188, 724\u2013734 (2012).","journal-title":"J. Immunol."},{"key":"2183_CR42","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.4049\/jimmunol.1400954","volume":"193","author":"H Fujiwara","year":"2014","unstructured":"Fujiwara, H. et al. Programmed death-1 pathway in host tissues ameliorates Th17\/Th1-mediated experimental chronic graft-versus-host disease. J. Immunol. 193, 2565\u20132573 (2014).","journal-title":"J. Immunol."},{"key":"2183_CR43","first-page":"2732","volume":"53","author":"BH Ye","year":"1993","unstructured":"Ye, B. H., Rao, P. H., Chaganti, R. S. & Dalla-Favera, R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53, 2732\u20132735 (1993).","journal-title":"Cancer Res."},{"key":"2183_CR44","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132\u20131148 (2019).","journal-title":"Immunity"},{"key":"2183_CR45","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/eji.201747034","volume":"47","author":"MM Xie","year":"2017","unstructured":"Xie, M. M. et al. Bcl6 promotes follicular helper T\u2010cell differentiation and PD\u20101 expression in a Blimp1\u2010independent manner in mice. Eur. J. Immunol. 47, 1136\u20131141 (2017).","journal-title":"Eur. J. Immunol."},{"key":"2183_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","volume":"31","author":"D Yu","year":"2009","unstructured":"Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457\u2013468 (2009).","journal-title":"Immunity"},{"key":"2183_CR47","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci. Immunol. 1, eaai859 (2016).","DOI":"10.1126\/sciimmunol.aai8593"},{"key":"2183_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adh1306","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun, Q. et al. BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1. Sci. Immunol. 8, eadh1306 (2023).","journal-title":"Sci. Immunol."},{"key":"2183_CR49","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood.V88.4.1234.bloodjournal8841234","volume":"88","author":"LT Smith","year":"1996","unstructured":"Smith, L. T., Hohaus, S., Gonzalez, D. A., Dziennis, S. E. & Tenen, D. G. PU.1 (Spi-1) and C\/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88, 1234\u20131247 (1996).","journal-title":"Blood"},{"key":"2183_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/JLB.5MR0321-145R","volume":"110","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Stem cell-like memory T cells: the generation and application. J. Leukoc. Biol. 110, 1209\u20131223 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"2183_CR51","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1182\/blood.2023021815","volume":"143","author":"A Mathioudaki","year":"2024","unstructured":"Mathioudaki, A. et al. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature. Blood 143, 1269\u20131281 (2024).","journal-title":"Blood"},{"key":"2183_CR52","doi-asserted-by":"crossref","unstructured":"Sun, Q. et al. STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection. J. Exp. Med. 220, e20220686 (2023).","DOI":"10.1084\/jem.20220686"},{"key":"2183_CR53","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1128\/MCB.01620-12","volume":"33","author":"SR Walker","year":"2013","unstructured":"Walker, S. R. et al. STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. Mol. Cell Biol. 33, 2879\u20132890 (2013).","journal-title":"Mol. Cell Biol."},{"key":"2183_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4049\/jimmunol.1000661","volume":"185","author":"H Dai","year":"2010","unstructured":"Dai, H. et al. Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. J. Immunol. 185, 803\u2013807 (2010).","journal-title":"J. Immunol."},{"key":"2183_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/ni1165","volume":"6","author":"HC Probst","year":"2005","unstructured":"Probst, H. C., McCoy, K., Okazaki, T., Honjo, T. & van den Broek, M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6, 280\u2013286 (2005).","journal-title":"Nat. Immunol."},{"key":"2183_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fimmu.2019.00306","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. CD8+CD122+PD-1+ Tregs synergize with costimulatory blockade of CD40\/CD154, but not B7\/CD28, to prolong murine allograft survival. Front. Immunol. 10, 306 (2019).","journal-title":"Front. Immunol."},{"key":"2183_CR57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/ajt.14437","volume":"18","author":"T Takahashi","year":"2018","unstructured":"Takahashi, T. et al. PD-1 expression on CD8+ T cells regulates their differentiation within lung allografts and is critical for tolerance induction. Am. J. Transpl. 18, 216\u2013225 (2018).","journal-title":"Am. J. Transpl."},{"key":"2183_CR58","doi-asserted-by":"publisher","first-page":"3758713","DOI":"10.1155\/2018\/3758713","volume":"2018","author":"MR Vieyra-Lobato","year":"2018","unstructured":"Vieyra-Lobato, M. R., Vela-Ojeda, J., Montiel-Cervantes, L., Lopez-Santiago, R. & Moreno-Lafont, M. C. Description of CD8+ regulatory T lymphocytes and their specific intervention in graft-versus-host and infectious diseases, autoimmunity, and cancer. J. Immunol. Res. 2018, 3758713 (2018).","journal-title":"J. Immunol. Res."},{"key":"2183_CR59","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/TP.0000000000002258","volume":"102","author":"S Bezie","year":"2018","unstructured":"Bezie, S., Anegon, I. & Guillonneau, C. Advances on CD8+ Treg cells and their potential in transplantation. Transplantation 102, 1467\u20131478 (2018).","journal-title":"Transplantation"},{"key":"2183_CR60","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.4049\/jimmunol.1200122","volume":"189","author":"M Suzuki","year":"2012","unstructured":"Suzuki, M. et al. CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J. Immunol. 189, 2118\u20132130 (2012).","journal-title":"J. Immunol."},{"key":"2183_CR61","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/hep.30061","volume":"68","author":"AE Taylor","year":"2018","unstructured":"Taylor, A. E. et al. Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis. Hepatology 68, 1905\u20131921 (2018).","journal-title":"Hepatology"},{"key":"2183_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fimmu.2018.00035","volume":"9","author":"H Zhong","year":"2018","unstructured":"Zhong, H. et al. TGF-beta-induced CD8+CD103+ regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells. Front. Immunol. 9, 35 (2018).","journal-title":"Front. Immunol."},{"key":"2183_CR63","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1172\/JCI81227","volume":"125","author":"S Bezie","year":"2015","unstructured":"Bezie, S. et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J. Clin. Invest. 125, 3952\u20133964 (2015).","journal-title":"J. Clin. Invest."},{"key":"2183_CR64","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI71533","volume":"124","author":"E Picarda","year":"2014","unstructured":"Picarda, E. et al. MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection. J. Clin. Invest. 124, 2497\u20132512 (2014).","journal-title":"J. Clin. Invest."},{"key":"2183_CR65","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1172\/JCI28801","volume":"117","author":"C Guillonneau","year":"2007","unstructured":"Guillonneau, C. et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J. Clin. Invest. 117, 1096\u20131106 (2007).","journal-title":"J. Clin. Invest."},{"key":"2183_CR66","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.xpro.2021.100351","volume":"2","author":"I Skordos","year":"2021","unstructured":"Skordos, I., Demeyer, A. & Beyaert, R. Analysis of T cells in mouse lymphoid tissue and blood with flow cytometry. STAR Protoc. 2, 100351 (2021).","journal-title":"STAR Protoc."},{"key":"2183_CR67","doi-asserted-by":"publisher","first-page":"134.e131","DOI":"10.1016\/j.jtct.2021.12.001","volume":"28","author":"J Gao","year":"2022","unstructured":"Gao, J. et al. Inhibition of IL-1 receptor-associated kinase 1 decreases murine acute graft-versus-host disease while preserving the graft-versus-lymphoma effect. Transpl. Cell Ther. 28, 134.e131\u2013134.e110 (2022).","journal-title":"Transpl. Cell Ther."},{"key":"2183_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12015-015-9625-5","volume":"12","author":"MZ Ratajczak","year":"2016","unstructured":"Ratajczak, M. Z. & Suszynska, M. Emerging strategies to enhance homing and engraftment of hematopoietic stem cells. Stem Cell Rev. Rep. 12, 121\u2013128 (2016).","journal-title":"Stem Cell Rev. Rep."},{"key":"2183_CR69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cyto.2008.03.002","volume":"42","author":"AD Panopoulos","year":"2008","unstructured":"Panopoulos, A. D. & Watowich, S. S. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and \u2018emergency\u2019 hematopoiesis. Cytokine 42, 277\u2013288 (2008).","journal-title":"Cytokine"},{"key":"2183_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101255","volume":"34","author":"X-J Huang","year":"2021","unstructured":"Huang, X.-J. Overcoming graft failure after haploidentical transplantation: is this a possibility? Best. Pract. Res. Clin. Haematol. 34, 101255 (2021).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"2183_CR71","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","volume":"9","author":"YJ Chang","year":"2022","unstructured":"Chang, Y. J., Pei, X. Y. & Huang, X. J. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 9, e919\u2013e929 (2022).","journal-title":"Lancet Haematol."},{"key":"2183_CR72","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1172\/JCI81229","volume":"125","author":"M Bleakley","year":"2015","unstructured":"Bleakley, M. et al. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts. J. Clin. Invest. 125, 2677\u20132689 (2015).","journal-title":"J. Clin. Invest."},{"key":"2183_CR73","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.21.01755","volume":"40","author":"M Bleakley","year":"2022","unstructured":"Bleakley, M. et al. Naive T-cell depletion to prevent chronic graft-versus-host disease. J. Clin. Oncol. 40, 1174\u20131185 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2183_CR74","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-009-9293-9","volume":"29","author":"YJ Chang","year":"2009","unstructured":"Chang, Y. J., Zhao, X. Y., Huo, M. R. & Huang, X. J. Expression of CD62L on donor CD4+ T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation. J. Clin. Immunol. 29, 696\u2013704 (2009).","journal-title":"J. Clin. Immunol."},{"key":"2183_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/bmt.2012.157","volume":"48","author":"F Milano","year":"2013","unstructured":"Milano, F., Nelson, J. L. & Delaney, C. Fetal maternal immunity and antileukemia activity in cord-blood transplant recipients. Bone Marrow Transpl. 48, 321\u2013322 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"2183_CR76","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa1602074","volume":"375","author":"F Milano","year":"2016","unstructured":"Milano, F. et al. Cord-blood transplantation in patients with minimal residual disease. N. Engl. J. Med. 375, 944\u2013953 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2183_CR77","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0301-472X(03)00160-7","volume":"31","author":"P Szabolcs","year":"2003","unstructured":"Szabolcs, P. et al. Coexistent na\u00efve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp. Hematol. 31, 708\u2013714 (2003).","journal-title":"Exp. Hematol."},{"key":"2183_CR78","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4049\/jimmunol.2100581","volume":"208","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Reinvestigation of classic T cell subsets and identification of novel cell subpopulations by single-cell RNA sequencing. J. Immunol. 208, 396\u2013406 (2022).","journal-title":"J. Immunol."},{"key":"2183_CR79","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ymthe.2019.07.014","volume":"27","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. CD8+CD103+ iTregs inhibit chronic graft-versus-host disease with lupus nephritis by the increased expression of CD39. Mol. Ther. 27, 1963\u20131973 (2019).","journal-title":"Mol. Ther."},{"key":"2183_CR80","doi-asserted-by":"crossref","unstructured":"Heinrichs, J. et al. CD8+Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+Tregs in mice. Oncoimmunology 5, e1146842 (2016).","DOI":"10.1080\/2162402X.2016.1146842"},{"key":"2183_CR81","doi-asserted-by":"crossref","unstructured":"Guo, H. et al. Distinct immune homeostasis remodeling patterns after HLA-matched and haploidentical transplantation. Adv. Sci. 11, e2400544 (2024).","DOI":"10.1002\/advs.202400544"},{"key":"2183_CR82","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2337\/db19-0057","volume":"68","author":"MJ Haller","year":"2019","unstructured":"Haller, M. J. et al. Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data. Diabetes 68, 1267\u20131276 (2019).","journal-title":"Diabetes"},{"key":"2183_CR83","doi-asserted-by":"crossref","unstructured":"Jacobsen, L. M. et al. Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes. JCI Insight 8, e161812 (2023).","DOI":"10.1172\/jci.insight.161812"},{"key":"2183_CR84","doi-asserted-by":"crossref","unstructured":"Theobald, S. J. et al. Signatures of T and B cell development, functional responses and PD-1 upregulation after HCMV latent infections and reactivations in Nod.Rag.Gamma mice humanized with cord blood CD34+ cells. Front. Immunol. 9, 2734 (2018).","DOI":"10.3389\/fimmu.2018.02734"},{"key":"2183_CR85","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1302315","volume":"192","author":"KPA MacDonald","year":"2014","unstructured":"MacDonald, K. P. A. et al. Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10. J. Immunol. 192, 3180\u20133189 (2014).","journal-title":"J. Immunol."},{"key":"2183_CR86","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","volume":"35","author":"AM Siegel","year":"2011","unstructured":"Siegel, A. M. et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 35, 806\u2013818 (2011).","journal-title":"Immunity"},{"key":"2183_CR87","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2011.09.017","volume":"35","author":"W Cui","year":"2011","unstructured":"Cui, W., Liu, Y., Weinstein, J. S., Craft, J. & Kaech, S. M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35, 792\u2013805 (2011).","journal-title":"Immunity"},{"key":"2183_CR88","doi-asserted-by":"publisher","unstructured":"Meyer, T. et al. Immunological reconstitution and infections after alloHCT\u2014a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis. Bone Marrow Transpl. https:\/\/doi.org\/10.1038\/s41409-024-02474-1 (2024).","DOI":"10.1038\/s41409-024-02474-1"},{"key":"2183_CR89","first-page":"42","volume":"6","author":"T Teshima","year":"2023","unstructured":"Teshima, T., Boelens, J. J. & Matsuoka, K. I. Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation. Blood Cell Ther. 6, 42\u201348 (2023).","journal-title":"Blood Cell Ther."},{"key":"2183_CR90","doi-asserted-by":"publisher","first-page":"104300","DOI":"10.1016\/j.cellimm.2021.104300","volume":"362","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Hodges, A., Chen, S. H. & Pan, P. Y. Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases. Cell Immunol. 362, 104300 (2021).","journal-title":"Cell Immunol."},{"key":"2183_CR91","doi-asserted-by":"publisher","unstructured":"Blanc, K. L. et al. ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.005 (2025).","DOI":"10.1016\/j.jcyt.2025.01.005"},{"key":"2183_CR92","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood 124, 843\u2013850 (2014).","journal-title":"Blood"},{"key":"2183_CR93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China\u2014recommendations from the Chinese Society of Hematology. J. Hematol. Oncol. 11, 33 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"2183_CR94","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1182\/blood-2011-11-389809","volume":"119","author":"XJ Huang","year":"2012","unstructured":"Huang, X. J. et al. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 119, 5584\u20135590 (2012).","journal-title":"Blood"},{"key":"2183_CR95","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-09-0691","volume":"15","author":"H Xiao-Jun","year":"2009","unstructured":"Xiao-Jun, H. et al. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies. Clin. Cancer Res. 15, 4777\u20134783 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2183_CR96","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka, D. et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transpl. 15, 825\u2013828 (1995).","journal-title":"Bone Marrow Transpl."},{"key":"2183_CR97","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.beha.2008.03.001","volume":"21","author":"PJ Martin","year":"2008","unstructured":"Martin, P. J. Study design and endpoints in graft-versus-host disease. Best. Pract. Res. Clin. Haematol. 21, 357\u2013372 (2008).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"2183_CR98","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"2183_CR99","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"2183_CR100","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"2183_CR101","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","volume":"88","author":"KR Cooke","year":"1996","unstructured":"Cooke, K. R. et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88, 3230\u20133239 (1996).","journal-title":"Blood"},{"key":"2183_CR102","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill, G. R. et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90, 3204\u20133213 (1997).","journal-title":"Blood"},{"key":"2183_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104273","volume":"361","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. Stem cell-like memory T cells: a perspective from the dark side. Cell Immunol. 361, 104273 (2021).","journal-title":"Cell Immunol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02183-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:48:51Z","timestamp":1744285731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02183-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study of human samples was approved by the Institutional Review Board of Peking University (Register number: IRB00001052-16027) and the Ethics Committee of Ruijin Hospital (Register number: 2020-15). The written informed consent was obtained from all subjects before study entry, in accordance with the Declaration of Helsinki, Guidelines for Good Clinical Practice, and relevant Chinese laws and regulations. Animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University School of Medicine (Register number: JUMC2023-140-A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"120"}}